Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Influenza

Free Subscription 20.05.2024 1 Arch Virol 1 Biochem Biophys Res Commun 3 BMC Pediatr 9 BMJ 1 Cell 1 Drugs 1 Epidemiol Infect 8 J Infect Dis 12 J Virol 3 JAMA 7 Lancet 3 N Engl J Med 2 PLoS Comput Biol 35 PLoS One 3 Proc Natl Acad Sci U S A 8 Vaccine 3 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Arch Virol

1. ASADIPOOYA K, Asadipooya A, Adatorwovor R
   Combination of spironolactone and DPP-4 inhibitors for treatment of SARS-CoV-2 infection: a literature review.
   Arch Virol. 2024;169:122.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

2. KULMA M, Sakanovic A, Bedina-Zavec A, Caserman S, et al
   Sequestration of membrane cholesterol by cholesterol-binding proteins inhibits SARS-CoV-2 entry into Vero E6 cells.
   Biochem Biophys Res Commun. 2024;716:149954.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

3. AL-IEDE M, Alhouri A, Marwa K, Alnajjar R, et al
   Respiratory syncytial virus in pediatric patients admitted to a tertiary center in Amman: clinical characteristics, and age-related patterns.
   BMC Pediatr. 2024;24:334.
   PubMed         Abstract available
   
   
4. JIANG Z, Fang C, Peng F, Fan W, et al
   Comparison of clinical characteristics and disease burden of febrile seizures in children with and without COVID-19.
   BMC Pediatr. 2024;24:329.
   PubMed         Abstract available
   
   
5. HUANG L, Ye C, Zhou R, Ji Z, et al
   Diagnostic value of routine blood tests in differentiating between SARS-CoV-2, influenza A, and RSV infections in hospitalized children: a retrospective study.
   BMC Pediatr. 2024;24:328.
   PubMed         Abstract available
   
   

   
   BMJ

6. WISE J
   Sixty seconds on . . . the pandemic treaty.
   BMJ. 2024;385:q1124.
   PubMed        
   
   
7. MAHASE E
   Hospitals are urged to increase use of virtual wards to cut admissions.
   BMJ. 2024;385:q1123.
   PubMed        
   
   
8. NOGRADY B
   Australia: Inductions and preterm births fell during early pandemic years.
   BMJ. 2024;385:q1112.
   PubMed        
   
   
9. 
   Seven days in medicine: 8-14 May 2024.
   BMJ. 2024;385:q1079.
   PubMed        
   
   
10. LANG K
    What do we know about covid-19's effects on the brain?
    BMJ. 2024;385:q897.
    PubMed        
    
    
11. NAKWEYA G
    Doctors in Kenya end strike after threat of court action.
    BMJ. 2024;385:q1088.
    PubMed        
    
    
12. MAHASE E
    Infective endocarditis: Coroner's report questions NICE guidance on prevention.
    BMJ. 2024;385:q1081.
    PubMed        
    
    
13. O'CONNOR RJ, Parkin A, Mir G, Mullard J, et al
    Work and vocational rehabilitation for people living with long covid.
    BMJ. 2024;385:e076508.
    PubMed        
    
    
14. LOOI MK
    Sixty seconds on . . . Apple Watch.
    BMJ. 2024;385:q1063.
    PubMed        
    
    

    
    Cell

15. HARTMANN JA, Cardoso MR, Talarico MCR, Kenney DJ, et al
    Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses.
    Cell. 2024;187:2393-2410.
    PubMed         Abstract available
    
    

    
    Drugs

16. ZHU C, Pang S, Liu J, Duan Q, et al
    Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines.
    Drugs. 2024;84:403-423.
    PubMed         Abstract available
    
    

    
    Epidemiol Infect

17. PARK JO, Cho HK, Jeon CH, Kim SH, et al
    Characteristics and biomarkers associated with mortality in COVID-19 patients presenting to the emergency department.
    Epidemiol Infect. 2024;152:e76.
    PubMed         Abstract available
    
    

    
    J Infect Dis

18. MOTSOENENG BM, Dhar N, Nunes MC, Krammer F, et al
    Hemagglutinin stalk-specific Fc-mediated functions are associated with protection against influenza-illness after seasonal influenza vaccination in pregnant women.
    J Infect Dis. 2024 May 14:jiae241. doi: 10.1093.
    PubMed         Abstract available
    
    
19. BEN MAMOUN C, Vydyam P
    Response to the Letter by Liu and Colleagues.
    J Infect Dis. 2024;229:1601.
    PubMed        
    
    
20. FOTOOH ABADI L, Sharma MB, Kelesidis T
    Single-Cell Profiling of the Differential In Vivo Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Lung Tissue Cell Subtypes at the Protein Level.
    J Infect Dis. 2024;229:1382-1386.
    PubMed         Abstract available
    
    
21. WONG M, Gain C, Sharma MB, Fotooh Abadi L, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Infection Alters Mediators of Lung Tissue Remodeling In Vitro and In Vivo.
    J Infect Dis. 2024;229:1372-1381.
    PubMed         Abstract available
    
    
22. KARABA AH, Morgenlander WR, Johnston TS, Hage C, et al
    Epitope Mapping of SARS-CoV-2 Spike Antibodies in Vaccinated Kidney Transplant Recipients Reveals Poor Spike Coverage Compared to Healthy Controls.
    J Infect Dis. 2023 Nov 29:jiad534. doi: 10.1093.
    PubMed         Abstract available
    
    
23. DOS RAMOS ALMEIDA CJL, Veras FP, Paiva IM, Schneider AH, et al
    Neutrophil Virucidal Activity Against SARS-CoV-2 Is Mediated by Neutrophil Extracellular Traps.
    J Infect Dis. 2024;229:1352-1365.
    PubMed         Abstract available
    
    
24. LEDUCQ V, Zafilaza K, Fauchois A, Ghidaoui E, et al
    Spike Protein Genetic Evolution in Patients at High Risk of Severe Coronavirus Disease 2019 Treated by Monoclonal Antibodies.
    J Infect Dis. 2024;229:1341-1351.
    PubMed         Abstract available
    
    
25. HAIDAR G, Hodges JC, Bilderback A, Lukanski A, et al
    Prospective assessment of humoral and cellular immune responses to a 3rd COVID-19 mRNA vaccine dose among immunocompromised individuals.
    J Infect Dis. 2023 Nov 16:jiad511. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Virol

26. MEADE PS, Bandawane P, Bushfield K, Hoxie I, et al
    Detection of clade 2.3.4.4b highly pathogenic H5N1 influenza virus in New York City.
    J Virol. 2024 May 15:e0062624. doi: 10.1128/jvi.00626.
    PubMed         Abstract available
    
    
27. VIOX EG, Bosinger SE, Douek DC, Schreiber G, et al
    Harnessing the power of IFN for therapeutic approaches to COVID-19.
    J Virol. 2024 Apr 23:e0120423. doi: 10.1128/jvi.01204.
    PubMed         Abstract available
    
    
28. MAO D, Liu S, Phan AT, Renner S, et al
    The TRAF3-DYRK1A-RAD54L2 complex maintains ACE2 expression to promote SARS-CoV-2 infection.
    J Virol. 2024 Apr 23:e0034724. doi: 10.1128/jvi.00347.
    PubMed         Abstract available
    
    
29. HAN Y, Yuan Z, Yi Z
    Identification of a membrane-associated element (MAE) in the C-terminal region of SARS-CoV-2 nsp6 that is essential for viral replication.
    J Virol. 2024 Apr 19:e0034924. doi: 10.1128/jvi.00349.
    PubMed         Abstract available
    
    
30. PEREZ DR
    A devastating blow: personal reflections on Argentina's scientific decline.
    J Virol. 2024 Apr 16:e0054924. doi: 10.1128/jvi.00549.
    PubMed         Abstract available
    
    
31. ISHIMARU H, Nishimura M, Shigematsu H, Marini MI, et al
    Epitopes of an antibody that neutralizes a wide range of SARS-CoV-2 variants in a conserved subdomain 1 of the spike protein.
    J Virol. 2024 Apr 16:e0041624. doi: 10.1128/jvi.00416.
    PubMed         Abstract available
    
    
32. TAKADA K, Orba Y, Kida Y, Wu J, et al
    Genes involved in the limited spread of SARS-CoV-2 in the lower respiratory airways of hamsters may be associated with adaptive evolution.
    J Virol. 2024 Apr 16:e0178423. doi: 10.1128/jvi.01784.
    PubMed         Abstract available
    
    
33. BOON ACM, Bricker TL, Fritch EJ, Leist SR, et al
    Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19.
    J Virol. 2024 Apr 9:e0190323. doi: 10.1128/jvi.01903.
    PubMed         Abstract available
    
    
34. YANG R, Han P, Han P, Li D, et al
    Molecular basis of hippopotamus ACE2 binding to SARS-CoV-2.
    J Virol. 2024 Apr 9:e0045124. doi: 10.1128/jvi.00451.
    PubMed         Abstract available
    
    
35. XIAO X, Fu Y, You W, Huang C, et al
    Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide.
    J Virol. 2024 Apr 4:e0157323. doi: 10.1128/jvi.01573.
    PubMed         Abstract available
    
    
36. BRUNET J, Choucha Z, Gransagne M, Tabbal H, et al
    A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model.
    J Virol. 2024 Apr 2:e0169323. doi: 10.1128/jvi.01693.
    PubMed         Abstract available
    
    
37. NAMBULLI S, Escriou N, Rennick LJ, Demers MJ, et al
    A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease.
    J Virol. 2024 Apr 2:e0176223. doi: 10.1128/jvi.01762.
    PubMed         Abstract available
    
    

    
    JAMA

38. XIE Y, Choi T, Al-Aly Z
    Mortality in Patients Hospitalized for COVID-19 vs Influenza in Fall-Winter 2023-2024.
    JAMA. 2024 May 15:e247395. doi: 10.1001/jama.2024.7395.
    PubMed        
    
    
39. 
    Audio Highlights.
    JAMA. 2024;331:e2318283.
    PubMed        
    
    
40. CHESHIRE WP, Dudenkov DV, Munipalli B
    Tilt Table Testing.
    JAMA. 2024;331:1494-1495.
    PubMed        
    
    

    
    Lancet

41. KOJIMA N, Adlhoch C, Mitja O, Dat VQ, et al
    Building global preparedness for avian influenza.
    Lancet. 2024 May 9:S0140-6736(24)00934-6. doi: 10.1016/S0140-6736(24)00934.
    PubMed        
    
    
42. WATTS G
    Alasdair Macintosh Geddes.
    Lancet. 2024;403:1846.
    PubMed        
    
    
43. AUJLA M
    Art, plunder, fragile fault lines.
    Lancet. 2024;403:1844-1845.
    PubMed        
    
    
44. USHER AD
    Organisations vie for control over pandemic financing.
    Lancet. 2024;403:1839-1840.
    PubMed        
    
    
45. GREENHALGH T, MacIntyre CR, Ungrin M, Wright JM, et al
    Airborne pathogens: controlling words won't control transmission.
    Lancet. 2024;403:1850-1851.
    PubMed        
    
    
46. YANG YT
    Protecting humanitarian aid workers: an urgent call.
    Lancet. 2024;403:1847.
    PubMed        
    
    
47. ABUZERR S, Zinser K
    Amplifying the voices of women in the Gaza Strip.
    Lancet. 2024;403:1848-1849.
    PubMed        
    
    

    
    N Engl J Med

48. HERBERT C, McManus DD, Soni A
    False Positive Covid-19 Rapid Antigen Tests. Reply.
    N Engl J Med. 2024;390:1836.
    PubMed        
    
    
49. YANG C, Espin E, Tebbutt SJ
    False Positive Covid-19 Rapid Antigen Tests.
    N Engl J Med. 2024;390:1835-1836.
    PubMed        
    
    
50. SCHUBACH A, Ricotta D, Kittleson MM
    To Preround or Not to Preround.
    N Engl J Med. 2024;390:1824-1826.
    PubMed        
    
    

    
    PLoS Comput Biol

51. LOPEZ VK, Cramer EY, Pagano R, Drake JM, et al
    Challenges of COVID-19 Case Forecasting in the US, 2020-2021.
    PLoS Comput Biol. 2024;20:e1011200.
    PubMed         Abstract available
    
    
52. ASPLIN P, Keeling MJ, Mancy R, Hill EM, et al
    Epidemiological and health economic implications of symptom propagation in respiratory pathogens: A mathematical modelling investigation.
    PLoS Comput Biol. 2024;20:e1012096.
    PubMed         Abstract available
    
    

    
    PLoS One

53. BRETANA NA, Kwon JA, Grant L, Galouzis J, et al
    Controlling COVID-19 outbreaks in the correctional setting: A mathematical modelling study.
    PLoS One. 2024;19:e0303062.
    PubMed         Abstract available
    
    
54. SHERAK RAG, Sajjadi H, Khimani N, Tolchin B, et al
    SOFA score performs worse than age for predicting mortality in patients with COVID-19.
    PLoS One. 2024;19:e0301013.
    PubMed         Abstract available
    
    
55. THAMPI N, Burhunduli T, Strain J, Raudanskis A, et al
    Detection of SARS-CoV-2 in schools using built environment testing in Ottawa, Canada: A multi-facility prospective surveillance study.
    PLoS One. 2024;19:e0300397.
    PubMed         Abstract available
    
    
56. HARRIS J, Germain J, McCoy E, Schofield R, et al
    Ethical guidance for conducting health research with online communities: A scoping review of existing guidance.
    PLoS One. 2024;19:e0302924.
    PubMed         Abstract available
    
    
57. FENG W, Zhao L, Ge Z, Zhao X, et al
    Association between physical activity and adolescent mental health in the post COVID-19: The chain mediating effect of self-esteem and social anxiety.
    PLoS One. 2024;19:e0301617.
    PubMed         Abstract available
    
    
58. ESPOSITO G, Hunashal Y, Percipalle M, Fogolari F, et al
    Assessing nanobody interaction with SARS-CoV-2 Nsp9.
    PLoS One. 2024;19:e0303839.
    PubMed         Abstract available
    
    
59. GUNAY-POLATKAN S, Caliskan S, Sigirli D
    Association of atherogenic indices with myocardial damage and mortality in COVID-19.
    PLoS One. 2024;19:e0302984.
    PubMed         Abstract available
    
    
60. PANAHI R, Ghorbanpour Z, Moradi B, Eidy F, et al
    The relationship between health literacy and the adoption of COVID-19 preventive behaviors: A cross-sectional study in Iran.
    PLoS One. 2024;19:e0299007.
    PubMed         Abstract available
    
    
61. UMEH GC, Cleenwerck de Kiev L, Mamza J, Atiku A, et al
    Symptoms of depression among outpatients with suspected COVID-19 in metropolitan Local Government Areas of Kaduna State, Nigeria.
    PLoS One. 2024;19:e0288567.
    PubMed         Abstract available
    
    
62. URAZAYEVA ST, Kurmangaliyeva SS, Kaliyev AA, Tussupkaliyeva KS, et al
    Attitude toward vaccination against COVID-19 and acceptance of the national "QazVac" vaccine in the Aktobe city population, West Kazakhstan: A cross-sectional survey.
    PLoS One. 2024;19:e0303854.
    PubMed         Abstract available
    
    
63. ZHOU Q, Zhao G, Pan Y, Zhang Y, et al
    The efficacy and safety of fluvoxamine in patients with COVID-19: A systematic review and meta-analysis from randomized controlled trials.
    PLoS One. 2024;19:e0300512.
    PubMed         Abstract available
    
    
64. SHYU D, Bliss P, Adams A, Cho RJ, et al
    Development and performance evaluation of a solenoid valve assisted low-cost ventilator on gas exchange and respiratory mechanics in a porcine model.
    PLoS One. 2024;19:e0303443.
    PubMed         Abstract available
    
    
65. DUNCAN G, Christensen WF, Handley C
    COVID-19 hotspot detection in a university setting.
    PLoS One. 2024;19:e0289254.
    PubMed         Abstract available
    
    
66. OLIVEIRA ES, Nascimento ALBD, Ferreira Junior WS, Albuquerque UP, et al
    How does prestige bias affect information recall during a pandemic?
    PLoS One. 2024;19:e0303512.
    PubMed         Abstract available
    
    
67. KHALIL B, Sharif-Askari NS, Hafezi S, Sharif-Askari FS, et al
    Vitamin D regulates COVID-19 associated severity by suppressing the NLRP3 inflammasome pathway.
    PLoS One. 2024;19:e0302818.
    PubMed         Abstract available
    
    
68. KASPERSKA A, Matysiak A, Cukrowska-Torzewska E
    Managerial (dis)preferences towards employees working from home: Post-pandemic experimental evidence.
    PLoS One. 2024;19:e0303307.
    PubMed         Abstract available
    
    
69. PARK J, Joo H, Kim D, Mase S, et al
    Cost-effectiveness of mask mandates on subways to prevent SARS-CoV-2 transmission in the United States.
    PLoS One. 2024;19:e0302199.
    PubMed         Abstract available
    
    
70. BISHOP-EDWARDS L, Taylor Buck E, Weich S
    The delivery of creative socially prescribed activities for people with serious mental health needs during lockdown: Learning about remote, digital and hybrid delivery.
    PLoS One. 2024;19:e0301550.
    PubMed         Abstract available
    
    
71. BABAR M, Qureshi B, Koubaa A
    Investigating the impact of data heterogeneity on the performance of federated learning algorithm using medical imaging.
    PLoS One. 2024;19:e0302539.
    PubMed         Abstract available
    
    
72. HUNTER PR, Brainard J
    Changing risk factors for developing SARS-CoV-2 infection from Delta to Omicron.
    PLoS One. 2024;19:e0299714.
    PubMed         Abstract available
    
    
73. ARGENIO KL, Day SE, D'Agostino EM, Neshteruk C, et al
    Increasing disparities in obesity and severe obesity prevalence among public elementary and middle school students in New York City, school years 2011-12 through 2019-20.
    PLoS One. 2024;19:e0302099.
    PubMed         Abstract available
    
    
74. XU W, Bao X, Lou X, Liu X, et al
    Feature fusion method for pulmonary tuberculosis patient detection based on cough sound.
    PLoS One. 2024;19:e0302651.
    PubMed         Abstract available
    
    
75. KHEZRI M, McKnight C, Weng CA, Kimball S, et al
    COVID-19 vaccination uptake and determinants of booster vaccination among persons who inject drugs in New York City.
    PLoS One. 2024;19:e0303394.
    PubMed         Abstract available
    
    
76. YANG Q, Chang A, Tong X, Jackson SL, et al
    Long-term cardiovascular disease outcomes in non-hospitalized medicare beneficiaries diagnosed with COVID-19: Population-based matched cohort study.
    PLoS One. 2024;19:e0302593.
    PubMed         Abstract available
    
    
77. NHACOLO A, Magaco A, Amosse F, Hunguana A, et al
    Perceptions and compliance with COVID-19 preventive measures in Southern and Central regions of Mozambique: A quantitative in-person household survey in the districts of Manhica and Quelimane.
    PLoS One. 2024;19:e0278439.
    PubMed         Abstract available
    
    
78. WANG B, Tong C, Chen T, Yang J, et al
    Evaluation of China's live streaming e-commerce industry policies based on a three-dimensional analysis framework.
    PLoS One. 2024;19:e0301451.
    PubMed         Abstract available
    
    
79. WASSIE GT, Ambelie YA, Adebabay T, Yeshiwas AG, et al
    Covid-19 vaccine uptake and its associated factors among adult population in Dangila district, Awi Zone, Northwest Ethiopia: A mixed method study.
    PLoS One. 2024;19:e0302531.
    PubMed         Abstract available
    
    
80. MEYER D, Lowensen K, Perrin N, Moore A, et al
    An evaluation of the impact of social and structural determinants of health on forgone care during the COVID-19 pandemic in Baltimore, Maryland.
    PLoS One. 2024;19:e0302064.
    PubMed         Abstract available
    
    
81. FUKUYAMA K, Mori Y, Ueshima H, Ito S, et al
    Medical resource usage for COVID-19 evaluated using the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
    PLoS One. 2024;19:e0303493.
    PubMed         Abstract available
    
    
82. YASEEN A, DeSantis SM, Sabharwal R, Talebi Y, et al
    Baseline characteristics of SARS-CoV-2 vaccine non-responders in a large population-based sample.
    PLoS One. 2024;19:e0303420.
    PubMed         Abstract available
    
    
83. GAO Y, Ma Y, Li Y, Zhao Y, et al
    Prevalence and correlates of mental disorders among Chinese overseas students during the COVID-19: A multi-regional cross-sectional analysis.
    PLoS One. 2024;19:e0303283.
    PubMed         Abstract available
    
    
84. THOMAZELLI LM, Pinho JRR, Dorlass EG, Ometto T, et al
    Evidence of reassortment of avian influenza A (H2) viruses in Brazilian shorebirds.
    PLoS One. 2024;19:e0300862.
    PubMed         Abstract available
    
    
85. BROWN RT, Zamora K, Rizzo A, Spar MJ, et al
    Improving measurement of functional status among older adults in primary care: A pilot study.
    PLoS One. 2024;19:e0303402.
    PubMed         Abstract available
    
    
86. RYS M, Schollaert E, Van Hoye G
    Living the employer brand during a crisis? A qualitative study on internal employer branding in times of the COVID-19 pandemic.
    PLoS One. 2024;19:e0303361.
    PubMed         Abstract available
    
    
87. SIMONSSON O, Fisher SD
    Mindfulness meditation use in Britain during the COVID-19 pandemic.
    PLoS One. 2024;19:e0303349.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

88. OTTER CJ, Renner DM, Fausto A, Tan LH, et al
    Interferon signaling in the nasal epithelium distinguishes among lethal and common cold coronaviruses and mediates viral clearance.
    Proc Natl Acad Sci U S A. 2024;121:e2402540121.
    PubMed         Abstract available
    
    
89. KITAMURA S, Lin TH, Lee CD, Takamura A, et al
    Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry.
    Proc Natl Acad Sci U S A. 2024;121:e2310677121.
    PubMed         Abstract available
    
    
90. XIE Y, Yang F, Huang J, He Y, et al
    Declining Chinese attitudes toward the United States amid COVID-19.
    Proc Natl Acad Sci U S A. 2024;121:e2322920121.
    PubMed         Abstract available
    
    

    
    Vaccine

91. CARNALLA M, Stern D, Arantxa Colchero M, Rangel-Moreno K, et al
    Who is getting COVID-19 boosters? A latent class analysis in a nationally representative sample of Mexican adults 60 years and over.
    Vaccine. 2024;42:3273-3276.
    PubMed         Abstract available
    
    
92. LIEVRE G, Sicsic J, Galmiche S, Charmet T, et al
    Are the 7C psychological antecedents associated with COVID-19 vaccine behaviours beyond intentions? A cross-sectional study on at-least-one-dose and up-to-date vaccination status, and uptake speed among adults in France.
    Vaccine. 2024 Apr 19:S0264-410X(24)00438-9. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
93. RAMOS-DUARTE VA, Orlowski A, Jaquenod de Giusti C, Corigliano MG, et al
    Safe plant Hsp90 adjuvants elicit an effective immune response against SARS-CoV2-derived RBD antigen.
    Vaccine. 2024;42:3355-3364.
    PubMed         Abstract available
    
    
94. MELNIKOW J, Padovani A, Zhang J, Miller M, et al
    Patient concerns and physician strategies for addressing COVID-19 vaccine hesitancy.
    Vaccine. 2024 Apr 15:S0264-410X(24)00437-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
95. WONG IOL, Wong C, Mak N, Dai A, et al
    Assessment of the impact of the vaccine pass policy on COVID-19 vaccine hesitancy and uptake among Chinese adults in Hong Kong.
    Vaccine. 2024 Apr 15:S0264-410X(24)00449-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
96. SUKIK L, Chemaitelly H, Ayoub HH, Coyle P, et al
    Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient.
    Vaccine. 2024 Apr 13:S0264-410X(24)00440-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
97. LEE JS, Choi H, Shin SH, Hwang MJ, et al
    Characterization of Brighton Collaboration criteria for myocarditis and pericarditis following COVID-19 vaccine in Korean adolescents.
    Vaccine. 2024 Apr 11:S0264-410X(24)00446-8. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
98. THAI H, Audet EC, Koestner R
    Motivation for COVID-19 Vaccination: Applying a Self-Determination Theory Perspective to a Global Health Crisis.
    Vaccine. 2024 Apr 9:S0264-410X(24)00439-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    

    
    Virology

99. LEE J, Naoe Y, Bang U, Nakagama Y, et al
    Neutralization sensitivity of SARS-CoV-2 Omicron variants FL.1 and GE.1 by therapeutic antibodies and XBB sera.
    Virology. 2024;595:110067.
    PubMed         Abstract available
    
    
100. GILLOT C, Tre-Hardy M, Cupaiolo R, Blairon L, et al
     Assessment of the neutralizing antibody response in Omicron breakthrough cases in healthcare workers who received the homologous booster of Moderna mRNA-1273.
     Virology. 2024;595:110082.
     PubMed         Abstract available
     
     
101. UENO S, Amarbayasgalan S, Sugiura Y, Takahashi T, et al
     Eight-amino-acid sequence at the N-terminus of SARS-CoV-2 nsp1 is involved in stabilizing viral genome replication.
     Virology. 2024;595:110068.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.